ROCHESTER HILLS, Mich., July 29, 2025--(BUSINESS WIRE)--InfuSystem Holdings, Inc. (NYSE American: INFU) ("InfuSystem" or the "Company"), a leading national health care service provider, facilitating ...
ROCHESTER HILLS, Mich., May 01, 2025--(BUSINESS WIRE)--InfuSystem Holdings, Inc. (NYSE American: INFU) ("InfuSystem" or the "Company"), a leading national health care service provider, facilitating ...
InfuSystem Holdings gains from NOPAIN ACT reimbursements as net income growth outpaces peers and revenue rebounds. Check out ...
Certain statements contained in this press release are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities ...
InfuSystem Holdings offers strong growth potential and appears attractively valued after reporting positive Q3 2025 earnings results. INFU's Patient Services segment, especially oncology and wound ...
ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--InfuSystem Holdings, Inc. (NYSE American: INFU) (“InfuSystem” or the “Company”), a leading national health care service provider, facilitating outpatient care ...
ROCHESTER HILLS, Mich.--(BUSINESS WIRE)-- InfuSystem Holdings, Inc. (NYSE American: INFU), (“InfuSystem” or the “Company), a leading national health care service provider, facilitating outpatient care ...
MADISON HEIGHTS -- InfuSystem Holdings Inc. (NYSE: INFU) this week reported a loss of $915,000 or 4 cents a share on revenue of $14.3 million in the first quarter ended March 31, compared to a loss of ...
Net revenues totaled $36.5 million, an increase of 3% vs. prior year. Patient Services net revenue was $22.4 million, an increase of 8% vs. prior year. Device Solutions net revenue was $14.1 million, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results